RESUMEN
Dermatoses are an increasingly common problem, particularly in developed countries. The causes of this phenomenon include genetic factors and environmental elements. More and more scientific reports suggest that the gut microbiome, more specifically its dysbiosis, also plays an important role in the induction and progression of diseases, including dermatological diseases. The gut microbiome is recognised as the largest endocrine organ, and has a key function in maintaining human homeostasis. In this review, the authors will take a close look at the link between the gut-skin axis and the pathogenesis of dermatoses such as atopic dermatitis, psoriasis, alopecia areata, and acne. The authors will also focus on the role of probiotics in remodelling the microbiome and the alleviation of dermatoses.
Asunto(s)
Alopecia Areata , Microbioma Gastrointestinal , Enfermedades de la Piel , Humanos , Disbiosis , PielRESUMEN
Skin aging is an inevitable and intricate process instigated, among others, by oxidative stress. The search for natural sources that inhibit this mechanism is a promising approach to preventing skin aging. The purpose of our study was to evaluate the composition of phenolic compounds in the micellar extract of Phaseolus vulgaris sprouts. The results of a liquid chromatography-mass spectrometry (LC-MS) analysis revealed the presence of thirty-two constituents, including phenolic acids, flavanols, flavan-3-ols, flavanones, isoflavones, and other compounds. Subsequently, the extract was assessed for its antioxidant, anti-inflammatory, anti-collagenase, anti-elastase, anti-tyrosinase, and cytotoxic properties, as well as for the evaluation of collagen synthesis. It was demonstrated that micellar extract from common bean sprouts has strong anti-aging properties. The performed WST-8 (a water-soluble tetrazolium salt) assay revealed that selected concentrations of extract significantly increased proliferation of human dermal fibroblasts compared to the control cells in a dose-dependent manner. A similar tendency was observed with respect to collagen synthesis. Our results suggest that micellar extract from Phaseolus vulgaris sprouts can be considered a promising anti-aging compound for applications in cosmetic formulations.
Asunto(s)
Antioxidantes , Fibroblastos , Phaseolus , Fitoquímicos , Extractos Vegetales , Phaseolus/química , Humanos , Fitoquímicos/farmacología , Fitoquímicos/química , Extractos Vegetales/farmacología , Extractos Vegetales/química , Antioxidantes/farmacología , Antioxidantes/química , Fibroblastos/efectos de los fármacos , Envejecimiento de la Piel/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Antiinflamatorios/farmacología , Antiinflamatorios/químicaRESUMEN
The reaction of glycerol with CO2 to produce glycerol carbonate was performed successfully in the presence of gold nanoparticles (AuNPs) supported by a metal-organic framework (MOF) constructed from mixed carboxylate (terephthalic acid and 1,3,5-benzenetricarboxylic acid). The most efficient were two AuNPs@MOF catalysts prepared from pre-synthesized MOF impregnated with Au3+ salt and subsequently reduced to AuNPs using H2 (catalyst 4%Au(H2)@MOF1) or reduced with NaBH4 (catalyst 4%Au@PEI-MOF1). Compared to existing catalysts, AuNPs@MOFs require simple preparation and operate under mild and sustainable conditions, i.e., a much lower temperature and the lowest CO2 overpressure ever reported, with MgCO3 having been found to be the optimal dehydrating agent. Although the yield of the process is still not competitive with previously developed systems, the most promising advantage is the highest TOF (78 h-1) ever reported for this reaction. The optimal parameters observed for AuNPs were also tested on AgNPs and CuNPs with promising results, suggesting their great potential for industrial application. The catalysts were characterized by XRD, TEM, SEM-EDS, ICP-MS, XPS, and porosity measurements, confirming that AuNPs are present in low concentration, uniformly distributed, and confined to the cavities of the MOF.
RESUMEN
Studies indicate that mitogen-activated protein kinases (MAPKs) exhibit activation and overexpression within psoriatic lesions. This study aimed to investigate alterations in the expression patterns of genes encoding MAPKs and microRNA (miRNA) molecules that potentially regulate their expression in human adult low-calcium high-temperature (HaCaT) keratinocytes when exposed to bacterial lipopolysaccharide A (LPS) and adalimumab. HaCaT cells underwent treatment with 1 µg/mL LPS for 8 hours, followed by treatment with 8 µg/mL adalimumab for 2, 8, or 24 hours. Untreated cells served as controls. The molecular analysis involved microarray, quantitative real-time polymerase chain reaction (RTqPCR), and enzyme-linked immunosorbent assay (ELISA) analyses. Changes in the expression profile of seven mRNAs: dual specificity phosphatase 1 (DUSP1), dual specificity phosphatase 3 (DUSP3), dual specificity phosphatase 4 (DUSP4), mitogen-activated protein kinase 9 (MAPK9), mitogen-activated protein kinase kinase kinase 2 (MAP3K2), mitogen-activated protein kinase kinase 2 (MAP2K2), and MAP kinase-activated protein kinase 2 (MAPKAPK2, also known as MK2) in cell culture exposed to LPS or LPS and the drug compared to the control. It was noted that miR-34a may potentially regulate the activity of DUSP1, DUSP3, and DUSP4, while miR-1275 is implicated in regulating MAPK9 expression. Additionally, miR-382 and miR-3188 are potential regulators of DUSP4 levels, and miR-200-5p is involved in regulating MAPKAPK2 and MAP3K2 levels. Thus, the analysis showed that these mRNA molecules and the proteins and miRNAs they encode appear to be useful molecular markers for monitoring the efficacy of adalimumab therapy.
Asunto(s)
Adalimumab , Lipopolisacáridos , MicroARNs , Proteínas Quinasas Activadas por Mitógenos , ARN Mensajero , Humanos , Lipopolisacáridos/farmacología , MicroARNs/genética , MicroARNs/metabolismo , Adalimumab/farmacología , ARN Mensajero/metabolismo , ARN Mensajero/genética , Proteínas Quinasas Activadas por Mitógenos/metabolismo , Células HaCaT , Queratinocitos/metabolismo , Queratinocitos/efectos de los fármacos , Perfilación de la Expresión Génica , Línea CelularRESUMEN
Studies indicate that mitogen-activated protein kinases (MAPKs) are activated and overexpressed in psoriatic lesions. The aim of the study was to assess changes in the expression pattern of genes encoding MAPKs and microRNA (miRNA) molecules potentially regulating their expression in human adult low-calcium high-temperature (HaCaT) keratinocytes exposed to bacterial lipopolysaccharide A (LPS) and cyclosporine A (CsA). HaCaT cells were treated with 1 µg/mL LPS for 8 h, followed by treatment with 100 ng/mL cyclosporine A for 2, 8, or 24 h. Untreated cells served as controls. The molecular analysis consists of microarray, quantitative real-time polymerase chain reaction, and enzyme-linked immunosorbent assay analyses. The statistical analysis of the obtained results was performed using Transcriptome Analysis Console and STATISTICA 13.5 PL with the statistical significance threshold of p < 0.05. Changes in the expression profile of six mRNAs: dual-specificity phosphatase 1 (DUSP1), dual-specificity phosphatase 4 (DUSP4), mitogen-activated protein kinase kinase 2 (MAP2K2), mitogen-activated protein kinase kinase 7 (MAP2K7), mitogen-activated protein kinase kinase kinase 2 (MAP3K2) and mitogen-activated protein kinase 9 (MAPK9) in cell culture exposed to LPS or LPS and the drug compared to the control. We observed that under the LPS and cyclosporine treatment, the expression o/ miR-34a, miR-1275, miR-3188, and miR-382 changed significantly (p < 0.05). We demonstrated a potential relationship between DUSP1 and miR-34a; DUSP4 and miR-34a, miR-382, and miR-3188; MAPK9 and miR-1275, MAP2K7 and mir-200-5p; MAP3K2 and mir-200-5p, which may be the subject of further research in the context of psoriasis.